{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:47Z","timestamp":1790634887370,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bcp.2017.04.022","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T22:15:16Z","timestamp":1493072116000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress"],"prefix":"10.1016","volume":"138","author":[{"given":"Punniyakoti T.","family":"Veeraveedu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koubun","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.04.022_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0952-7915(01)00306-5","article-title":"IL-1 and IL-18 receptors, and their extended family","volume":"14","author":"Sims","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","article-title":"A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor","volume":"258","author":"Tominaga","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2017.04.022_b0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2017.04.022_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines","volume":"223","author":"Arend","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2017.04.022_b0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2005.10.004","article-title":"An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor","volume":"23","author":"Dinarello","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2017.04.022_b0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2017.04.022_b0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCRESAHA.110.218867","article-title":"Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice","volume":"107","author":"Miller","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.04.022_b0040","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2017.04.022_b0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bcp.2017.04.022_b0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/erm.10.25","article-title":"ST2: a novel biomarker for heart failure","volume":"10","author":"Bhardwaj","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.bcp.2017.04.022_b0055","doi-asserted-by":"crossref","first-page":"e95055","DOI":"10.1371\/journal.pone.0095055","article-title":"Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome","volume":"9","author":"Demyanets","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2017.04.022_b0060","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jacc.2008.07.045","article-title":"Serum soluble ST2 as a biochemical marker of acute heart failure: future areas of research","volume":"52","author":"D\u00edez","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2017.04.022_b0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2840-10-101","article-title":"Toll\/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction","volume":"10","author":"Fousteris","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2017.04.022_b0070","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.CIR.0000127958.21003.5A","article-title":"Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction","volume":"109","author":"Shimpo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2017.04.022_b0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2017.04.022_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","article-title":"Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction","volume":"55","author":"Weir","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2017.04.022_b0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1189\/jlb.0606422","article-title":"ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion","volume":"81","author":"Fagundes","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2017.04.022_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","article-title":"A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2","volume":"173","author":"Leung","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0095","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1073\/pnas.95.12.6930","article-title":"T1\/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function","volume":"95","author":"L\u00f6hning","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2017.04.022_b0100","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.4049\/jimmunol.166.11.6633","article-title":"A novel pathway regulating lipopolysaccharide-induced shock by ST2\/T1 via inhibition of Toll-like receptor 4 expression","volume":"166","author":"Sweet","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0105","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbrc.2006.10.166","article-title":"Pretreatment with soluble ST2 reduces warm hepatic ischemia\/reperfusion injury","volume":"351","author":"Yin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2017.04.022_b0110","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.1201042109","article-title":"Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice","volume":"109","author":"Yasuda","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2017.04.022_b0115","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2017.04.022_b0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.94.5.1109","article-title":"Transthoracic echocardiography in models of cardiac disease in the mouse","volume":"94","author":"Tanaka","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2017.04.022_b0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurheartj\/ehm008","article-title":"Hypertrophy and inflammation: too much for one heart","volume":"28","author":"Bayes-Genis","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2017.04.022_b0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpcardio0158","article-title":"Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease","volume":"2","author":"D\u00edez","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2017.04.022_b0135","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","article-title":"Cardiac fibroblasts: friend or foe?","volume":"291","author":"Baudino","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2017.04.022_b0140","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.04.022_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(99)06187-5","article-title":"Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy","volume":"355","author":"Marian","year":"2000","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bcp.2017.04.022_b0150","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1073\/pnas.1424236112","article-title":"Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2017.04.022_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: double-edged swords","volume":"15","author":"Hedayat","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bcp.2017.04.022_b0160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2017.04.022_b0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.81.5.664","article-title":"Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload","volume":"81","author":"Shioi","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.04.022_b0170","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.188.8.1485","article-title":"Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells","volume":"188","author":"Xu","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2017.04.022_b0175","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2017.04.022_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharmthera.2011.02.005","article-title":"The IL-33\/ST2 pathway\u2013A new therapeutic target in cardiovascular disease","volume":"131","author":"Miller","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2017.04.022_b0190","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2017.04.022_b0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0200","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2017.04.022_b0205","article-title":"Inflammation in cardiac disease: focus on Interleukin-33\/ST2 pathway","volume":"1","author":"Caselli","year":"2014","journal-title":"Inflamm. Cell Signal."},{"key":"10.1016\/j.bcp.2017.04.022_b0210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217302393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217302393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T11:27:55Z","timestamp":1574940475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217302393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":42,"alternative-id":["S0006295217302393"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.04.022","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}